Santa Cruz Biotechnology

MDM2 (SMP14)

#sc-965 · western blot

147
Citing papers
5.1k
Combined citations
Supplier page Find this product

Research areas

Cancer-related Molecular Pathways30Ubiquitin and proteasome pathways12Epigenetics and DNA Methylation7RNA modifications and cancer6Autophagy in Disease and Therapy5Cancer, Hypoxia, and Metabolism5Cell death mechanisms and regulation5Cancer, Lipids, and Metabolism3

Papers citing this product

1
RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer
Nature·2014·634 cit.·DOI
2
MDM4 is a key therapeutic target in cutaneous melanoma
Nature Medicine·2012·305 cit.·DOI
3
NDRG1 Is Necessary for p53-dependent Apoptosis
Journal of Biological Chemistry·2004·220 cit.·DOI
4
Nongenotoxic activation of the p53 pathway as a therapeutic strategy for multiple myeloma
Blood·2005·179 cit.·DOI
5
Mechanical cues control mutant p53 stability through a mevalonate–RhoA axis
Nature Cell Biology·2017·163 cit.·DOI
6
NML-mediated rRNA base methylation links ribosomal subunit formation to cell proliferation in a p53-dependent manner
Journal of Cell Science·2016·111 cit.·DOI
7
DNA damage strength modulates a bimodal switch of p53 dynamics for cell-fate control
BMC Biology·2013·109 cit.·DOI
8
C16-ceramide is a natural regulatory ligand of p53 in cellular stress response
Nature Communications·2018·102 cit.·DOI
9
Autophagic degradation of the inhibitory p53 isoform Δ133p53α as a regulatory mechanism for p53-mediated senescence
Nature Communications·2014·96 cit.·DOI
10
Osthole inhibits triple negative breast cancer cells by suppressing STAT3
Journal of Experimental & Clinical Cancer Research·2018·96 cit.·DOI

Rate this reagent

Used this in your lab? Leave a quick rating. Reviews are anonymous and verified by academic email before they appear.

Your email is never shown publicly.